Loading clinical trials...
Loading clinical trials...
An Observational Multicenter Clinical Study to Assess the Long-Term Safety of the CyPass Micro-Stent in Patients With Primary Open Angle Glaucoma Who Have Completed Participation in the COMPASS Trial
Conditions
Interventions
CyPass Micro-Stent
Cataract Surgery
Locations
22
United States
Alcon Investigative Site
Glendale, Arizona, United States
Alcon Investigative Site
Fayetteville, Arkansas, United States
Alcon Investigative Site
La Jolla, California, United States
Alcon Investigative Site
Orange, California, United States
Alcon Investigative Site
Fort Collins, Colorado, United States
Alcon Investigative Site
Parker, Colorado, United States
Start Date
March 30, 2016
Primary Completion Date
April 18, 2018
Completion Date
April 18, 2018
Last Updated
January 24, 2024
NCT01252849
NCT01166659
NCT01085357
NCT00902109
Lead Sponsor
Alcon Research
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions